CAMBRIDGE, Mass., Oct. 10, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating, often fatal rare diseases, announced that the Company will host a conference call and live audio webcast at 8:30 a.m. EDT on Wednesday, October 30, 2013, to provide a business update and to discuss its third-quarter financial and operational results.
Help employers find you! Check out all the jobs and post your resume.
